Intertumoral heterogeneity within medulloblastoma subgroups FMG Cavalli, M Remke, L Rampasek, J Peacock, DJH Shih, B Luu, ... Cancer cell 31 (6), 737-754. e6, 2017 | 1075 | 2017 |
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus V Ramaswamy, M Remke, E Bouffet, S Bailey, SC Clifford, F Doz, M Kool, ... Acta neuropathologica 131, 821-831, 2016 | 619 | 2016 |
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial B Lannering, S Rutkowski, F Doz, B Pizer, G Gustafsson, A Navajas, ... Journal of clinical oncology 30 (26), 3187-3193, 2012 | 370 | 2012 |
Divergent clonal selection dominates medulloblastoma at recurrence AS Morrissy, L Garzia, DJH Shih, S Zuyderduyn, X Huang, P Skowron, ... Nature 529 (7586), 351-357, 2016 | 347 | 2016 |
Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International … LM Hoffman, SEM Veldhuijzen van Zanten, N Colditz, J Baugh, B Chaney, ... Journal of clinical oncology 36 (19), 1963-1972, 2018 | 344 | 2018 |
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants KW Pajtler, SC Mack, V Ramaswamy, CA Smith, H Witt, A Smith, ... Acta neuropathologica 133, 5-12, 2017 | 314 | 2017 |
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts DW Ellison, M Kocak, D Figarella-Branger, G Felice, G Catherine, ... Journal of negative results in biomedicine 10, 1-13, 2011 | 309 | 2011 |
Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics P Modena, E Lualdi, F Facchinetti, J Veltman, JF Reid, S Minardi, ... Journal of Clinical Oncology 24 (33), 5223-5233, 2006 | 246 | 2006 |
Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro‐Oncology Group G Perilongo, M Massimino, G Sotti, T Belfontali, L Masiero, L Rigobello, ... Medical and Pediatric Oncology: The Official Journal of SIOP—International …, 1997 | 234 | 1997 |
Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation E Bouffet, G Perilongo, A Canete, M Massimino Medical and Pediatric Oncology: The Official Journal of SIOP—International …, 1998 | 225 | 1998 |
High response rate to cisplatin/etoposide regimen in childhood low-grade glioma M Massimino, F Spreafico, G Cefalo, R Riccardi, JD Tesoro-Tess, ... Journal of clinical oncology 20 (20), 4209-4216, 2002 | 218 | 2002 |
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis V Ramaswamy, T Hielscher, SC Mack, A Lassaletta, T Lin, KW Pajtler, ... Journal of clinical oncology 34 (21), 2468-2477, 2016 | 192 | 2016 |
Molecular, pathological, radiological, and immune profiling of non-brainstem pediatric high-grade glioma from the HERBY phase II randomized trial A Mackay, A Burford, V Molinari, DTW Jones, E Izquierdo, ... Cancer cell 33 (5), 829-842. e5, 2018 | 181 | 2018 |
Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma L Gandola, M Massimino, G Cefalo, C Solero, F Spreafico, E Pecori, ... Journal of Clinical Oncology 27 (4), 566-571, 2009 | 179 | 2009 |
Childhood medulloblastoma M Massimino, V Biassoni, L Gandola, ML Garrè, G Gatta, F Giangaspero, ... Critical reviews in oncology/hematology 105, 35-51, 2016 | 178 | 2016 |
Pediatric low-grade gliomas: implications of the biologic era RJ Packer, S Pfister, E Bouffet, R Avery, P Bandopadhayay, M Bornhorst, ... Neuro-oncology 19 (6), 750-761, 2017 | 165 | 2017 |
Pediatric low-grade gliomas: next biologically driven steps DTW Jones, MW Kieran, E Bouffet, S Alexandrescu, P Bandopadhayay, ... Neuro-oncology 20 (2), 160-173, 2018 | 155 | 2018 |
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma H Suzuki, SA Kumar, S Shuai, A Diaz-Navarro, A Gutierrez-Fernandez, ... Nature 574 (7780), 707-711, 2019 | 153 | 2019 |
Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: a matched-cohort analysis on behalf of the SIOP-E-HGG … GO Janssens, L Gandola, S Bolle, H Mandeville, M Ramos-Albiac, ... European journal of cancer 73, 38-47, 2017 | 148 | 2017 |
Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study M Sabel, G Fleischhack, S Tippelt, G Gustafsson, F Doz, R Kortmann, ... Journal of neuro-oncology 129, 515-524, 2016 | 145 | 2016 |